Tags RBC Kinase HotSpot

Tag: RBC Kinase HotSpot

Reaction Bio Receives National Cancer Institute Grant for Epigenetic Platform

MALVERN, Pa. -- Reaction Biology Corporation (RBC) announced today that it has been awarded a Phase II SBIR grant from the National Cancer Institute to expand the reach of its Methyltransferase HotSpot drug discovery platform. The $1.2 million, two-year grant will help fund an expansion of RBC's methyltransferase screens from 14 to 35 or more.

WHAT'S NEWS